Story · Medicine & Biotech

STAT+: Pharmalittle: We’re reading about a Roche breast cancer pill, obesity drugs in children, and more

3 outlets · first reported by WSJ Health on · latest · 9 hours of coverage

Rise and shine, everyone, another busy day is on the way. And it is getting off to a pleasant start here on the Pharmalot campus, where clear blue skies and comfy breezes are greeting us. As for the official mascots, they are happily snoozing in their respective corners. As for us, we are firing up… (STAT News)

Coverage, in order

  1. first WSJ Health mainstream
    Roche Secures First U.S. Approval for New Breast-Cancer Pill

    The green light from the Food and Drug Administration marks the first approval for what Roche says could become the company’s top-selling product.

  2. STAT News indie
    STAT+: Pharmalittle: We’re reading about a Roche breast cancer pill, obesity drugs in children, and more

    Rise and shine, everyone, another busy day is on the way. And it is getting off to a pleasant start here on the Pharmalot campus, where clear blue skies and comfy breezes are greeting us. As for the official mascots, they are happily snoozing in their respective corners. As for us, we are firing up…

  3. Roche breast cancer pill cleared by FDA

    Wilserdly’s U.S. approval is seen by analysts as a “key first step” in an important launch for Roche, which has claimed the drug could become its top-selling product.

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.